Developer docs
API playgroundTry for free, no card

Search company profiles

Cambridge Angels group

Full company profile

uuid00059pl

Namestring
Cambridge Angels group
Legal namestring
Cambridge Angels Group Limited
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Cambridge Angels is a UK business angel network founded in 2001 by Robert Sansom and David Cleevely, operating as Cambridge Angels Group Limited out of the Cambridge/Silicon Fen ecosystem with a registered office in Oakham, England and Wales. The group is an invitation-only membership network capped at 65 individual members, the large majority of whom are exited entrepreneurs in technology and healthcare, complemented by six corporate members from venture capital (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise. Governance is provided by co-chairs Amy Weatherup and Robert Swann, a board of ~13 members, and a small professional team led since October 2025 by CEO Emmi Nicholl, with Charlotte Kirby in management.

The group's core offering is curated early-stage equity investment in UK-registered companies, typically the first equity round, with ticket sizes of £150k-£1.5m per company and a stated target return of 10x initial investment within 5-10 years. Investment criteria focus on science/engineering-based or IP-rich technology and healthcare-enabling tools targeting B2B markets with a £100m+ opportunity. Since inception the network has deployed £150m+ into more than 120-150 portfolio companies spanning mental health technology (Augmentive.io), energy management (xWatts), medical devices (Microneedle Solutions, MNS, Orthofuse), battery technology (Illumion), and pest control technology (Spotta). Internally, Cambridge Angels uses AI-assisted screening of pitch decks to triage deal flow before member pitching sessions, and processes were reformed in 2024 to shorten the investment cycle. An Emeritus membership category was introduced in 2024 to formalise alumni retention.

Cambridge Angels operates as a non-profit-style group and is unregulated by the UK Financial Conduct Authority. It charges no pitching, due diligence, or carry fees to portfolio companies, and its operational costs are funded by membership fees from individual members plus corporate sponsorship, with HSBC Innovation Banking serving as the network's principal supporter. Distribution to entrepreneurs runs through a top-of-funnel mix of website content, LinkedIn, published portfolio and angel interviews, free office-hours feedback sessions, and regular pitching sessions; distribution to investors is referral-based through the invitation-only membership process.

Short descriptiontext

Cambridge Angels is a UK business angel network founded in 2001 that provides smart capital from exited entrepreneurs to early-stage technology and healthcare companies. With up to 65 invitation-only members plus six corporate VC partners, the group invests £150k-£1.5m per company and has backed over 150 portfolio companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
angel investment network, early-stage equity funding, seed venture capital, business angel network, startup growth mentorship
Industry1 code
PRIMARYFSANAAAI
Micro-VC & Angel Funds
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Angel Investment / Early-Stage Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Membership fees and sponsorship
TypeSubscription Recurring
Description

Cambridge Angels' costs are funded through membership fees and sponsorship. No charges are levied on companies seeking investment, nor do they charge pitching or 'carry' fees.

cambridgeangels.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cambridge Angels is an invitation-only business angel network that pools capital from up to 65 high-net-worth members (predominantly exited entrepreneurs) to invest £150k–£1.5m equity rounds into early-stage UK technology and healthcare companies. It additionally provides portfolio support through mentorship, office hours, pitching sessions, and ecosystem networking, without charging any pitching, due diligence, or carry fees to investee companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over £150m invested in 120+ portfolio companies since 2001
+2 more records
Product overview1 text field

Cambridge Angels is a UK business angel network founded in 2001, providing smart capital from exited entrepreneurs to early-stage technology and healthcare companies. The organization offers investment services, mentorship, networking opportunities, and portfolio support rather than a traditional technology product. Services include curated deal flow for investors, access to experienced entrepreneurs as mentors, office hours for feedback, pitch sessions, and an investment criteria framework covering management teams, funding requirements (£150k-£1.5m), technology focus (science/engineering-based or IP-rich), B2B markets, and exit strategies.

Product and service6 records
1Seed and Series A Angel Investment
CategoryAngel Investment / Early-Stage Venture Capital
Description

Equity investment of typically £150k–£1.5m per company, usually the first equity round, into UK-registered early-stage technology and healthcare companies with credible teams, IP-rich or science/engineering-based propositions, and B2B markets. Members invest individually with the option (not obligation) to participate in any given round.

2Investor Membership
CategoryAngel Investment / Early-Stage Venture Capital
Description

Invitation-only membership for high-net-worth individuals (capped at 65) plus several corporate VC members, granting access to curated deal flow, co-investment opportunities, and the Cambridge Angels peer network. Membership is funded by recurring annual fees.

3Office Hours for Entrepreneurs
CategoryMentorship and Founder Support
Description

Free, one-on-one, no-obligation feedback sessions for entrepreneurs from experienced Cambridge Angels investor members, used as a top-of-funnel engagement and pre-screening touchpoint.

4Pitching Sessions
CategoryDeal Origination and Due Diligence
Description

Regular pitching sessions to which screened companies meeting Cambridge Angels' investment criteria (UK-registered, science/engineering or IP-rich, B2B, £100m+ market, 10x exit path) are invited to present to the full membership.

5Portfolio Company Mentorship and Network Access
CategoryPortfolio Support Services
Description

Ongoing post-investment support for portfolio companies, including introductions to customer and partner networks, strategic advisory from exited entrepreneur members, and access to a peer community of fellow portfolio companies.

6Follow-on Capital Access via Corporate VC Members
CategoryFollow-on Funding Facilitation
Description

Pathway for portfolio companies to access later-stage venture capital through Cambridge Angels' six corporate VC members (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthersAnnounced on2025-10-23
Description

Emmi Nicholl was promoted to CEO of Cambridge Angels, overseeing the group's activities, screening investment opportunities, and facilitating pitching and support events.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

UK equity crowdfunding platform enabling retail and HNW investors to back early-stage companies. Competes with Cambridge Angels for UK seed-stage deal flow and is increasingly used by founders seeking faster, broader capital raises with marketing benefits.

TypeEmerging player
Description

UK startup funding and legal infrastructure platform that streamlines fundraising, cap tables, and SEIS/EIS administration. Comparable as part of the broader UK seed-funding ecosystem that Cambridge Angels operates in, though focused on tooling rather than direct investment.

TypeBroad incumbent
Description

London-based early-stage venture fund investing in European technology companies at seed and pre-seed. Comparable in early-stage UK technology focus but operates via institutional fund structure rather than angel syndication.

TypeDirect peer
Description

UK angel-led investment platform/network that co-invests alongside lead angels into early-stage UK companies. Comparable in target market (UK seed-stage companies), investor base (HNW individuals), and value proposition (curated deal flow plus syndicate structure).

TypeBroad incumbent
Description

UK deep-tech venture capital firm and corporate member of Cambridge Angels. Provides later-stage capital to portfolio companies and overlaps in thesis (technology-rich, IP-heavy UK companies) but operates at Series A and beyond rather than seed — making it both a partner and a broader incumbent.

TypeDirect peer
Description

UK investment firm specialising in university spin-out and IP-rich technology investments. Parkwalk is a corporate member of Cambridge Angels but also operates its own funds targeting a very similar thesis, making it a close functional peer in the Cambridge deep-tech ecosystem.

TypeBroad incumbent
Description

UK venture arm of Octopus Group investing across seed to growth stages in UK and European technology companies. Comparable as a UK-based investor targeting early-stage B2B technology with similar sector breadth but materially larger cheque sizes.

TypeBroad incumbent
Description

UK early-stage venture capital firm and corporate member of Cambridge Angels. Compares as an institutional early-stage investor into UK technology and healthcare, with a similar sector focus but operating through larger fund vehicles rather than an angel syndicate.

TypeDirect peer
Description

UK university-region angel network based in Oxford with a structurally similar model — pooling HNW investors (often exited operators) to invest in early-stage UK companies. Directly comparable to Cambridge Angels as a fellow 'Oxbridge-adjacent' angel network targeting IP-rich spin-outs and B2B startups.

TypeDirect peer
Description

UK-headquartered online platform connecting angel investors with early-stage companies seeking funding. Comparable as a curated deal flow intermediary for HNW investors investing into UK startups, though with a broader geographic mandate than Cambridge Angels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment139 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Angels group

Angel Investment / Early-Stage Venture Capitalcambridgeangels.com

Cambridge Angels is a UK business angel network founded in 2001 that provides smart capital from exited entrepreneurs to early-stage technology and healthcare companies. With up to 65 invitation-only members plus six corporate VC partners, the group invests £150k-£1.5m per company and has backed over 150 portfolio companies.

What Cambridge Angels group does

Cambridge Angels is a UK business angel network founded in 2001 by Robert Sansom and David Cleevely, operating as Cambridge Angels Group Limited out of the Cambridge/Silicon Fen ecosystem with a registered office in Oakham, England and Wales. The group is an invitation-only membership network capped at 65 individual members, the large majority of whom are exited entrepreneurs in technology and healthcare, complemented by six corporate members from venture capital (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise. Governance is provided by co-chairs Amy Weatherup and Robert Swann, a board of ~13 members, and a small professional team led since October 2025 by CEO Emmi Nicholl, with Charlotte Kirby in management.

The group's core offering is curated early-stage equity investment in UK-registered companies, typically the first equity round, with ticket sizes of £150k-£1.5m per company and a stated target return of 10x initial investment within 5-10 years. Investment criteria focus on science/engineering-based or IP-rich technology and healthcare-enabling tools targeting B2B markets with a £100m+ opportunity. Since inception the network has deployed £150m+ into more than 120-150 portfolio companies spanning mental health technology (Augmentive.io), energy management (xWatts), medical devices (Microneedle Solutions, MNS, Orthofuse), battery technology (Illumion), and pest control technology (Spotta). Internally, Cambridge Angels uses AI-assisted screening of pitch decks to triage deal flow before member pitching sessions, and processes were reformed in 2024 to shorten the investment cycle. An Emeritus membership category was introduced in 2024 to formalise alumni retention.

Cambridge Angels operates as a non-profit-style group and is unregulated by the UK Financial Conduct Authority. It charges no pitching, due diligence, or carry fees to portfolio companies, and its operational costs are funded by membership fees from individual members plus corporate sponsorship, with HSBC Innovation Banking serving as the network's principal supporter. Distribution to entrepreneurs runs through a top-of-funnel mix of website content, LinkedIn, published portfolio and angel interviews, free office-hours feedback sessions, and regular pitching sessions; distribution to investors is referral-based through the invitation-only membership process.

Cambridge Angels group firmographics

Firmographics
Name
Cambridge Angels group
Legal name
Cambridge Angels Group Limited
Website
https://cambridgeangels.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
51–100 employees
Short description
Cambridge Angels is a UK business angel network founded in 2001 that provides smart capital from exited entrepreneurs to early-stage technology and healthcare companies. With up to 65 invitation-only members plus six corporate VC partners, the group invests £150k-£1.5m per company and has backed over 150 portfolio companies.
Ownership category
akta.pro rank

Cambridge Angels group industry classification

Industry
Product category
Angel Investment / Early-Stage Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAI
Micro-VC & Angel Funds

Keywords

  • Angel investment network
  • Early-stage equity funding
  • Seed venture capital
  • Business angel network
  • Startup growth mentorship

Where Cambridge Angels group is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Cambridge Angels group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Membership fees and sponsorship: Cambridge Angels' costs are funded through membership fees and sponsorship. No charges are levied on companies seeking investment, nor do they charge pitching or 'carry' fees.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Cambridge Angels group product offering

Product offering

Core offering

Cambridge Angels is an invitation-only business angel network that pools capital from up to 65 high-net-worth members (predominantly exited entrepreneurs) to invest £150k–£1.5m equity rounds into early-stage UK technology and healthcare companies. It additionally provides portfolio support through mentorship, office hours, pitching sessions, and ecosystem networking, without charging any pitching, due diligence, or carry fees to investee companies.

Product overview

Cambridge Angels is a UK business angel network founded in 2001, providing smart capital from exited entrepreneurs to early-stage technology and healthcare companies. The organization offers investment services, mentorship, networking opportunities, and portfolio support rather than a traditional technology product. Services include curated deal flow for investors, access to experienced entrepreneurs as mentors, office hours for feedback, pitch sessions, and an investment criteria framework covering management teams, funding requirements (£150k-£1.5m), technology focus (science/engineering-based or IP-rich), B2B markets, and exit strategies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seed and Series A Angel Investment Equity investment of typically £150k–£1.5m per company, usually the first equity round, into UK-registered early-stage technology and healthcare companies with credible teams, IP-rich or science/engineering-based propositions, and B2B markets. Members invest individually with the option (not obligation) to participate in any given round.
  • Investor Membership Invitation-only membership for high-net-worth individuals (capped at 65) plus several corporate VC members, granting access to curated deal flow, co-investment opportunities, and the Cambridge Angels peer network. Membership is funded by recurring annual fees.
  • Office Hours for Entrepreneurs Free, one-on-one, no-obligation feedback sessions for entrepreneurs from experienced Cambridge Angels investor members, used as a top-of-funnel engagement and pre-screening touchpoint.
  • Pitching Sessions Regular pitching sessions to which screened companies meeting Cambridge Angels' investment criteria (UK-registered, science/engineering or IP-rich, B2B, £100m+ market, 10x exit path) are invited to present to the full membership.
  • Portfolio Company Mentorship and Network Access Ongoing post-investment support for portfolio companies, including introductions to customer and partner networks, strategic advisory from exited entrepreneur members, and access to a peer community of fellow portfolio companies.
  • Follow-on Capital Access via Corporate VC Members Pathway for portfolio companies to access later-stage venture capital through Cambridge Angels' six corporate VC members (ACF Investors, Albion VC, Amadeus Capital Partners, Martlet, Parkwalk Advisors, Playfair Capital) and Cambridge Enterprise.

Quantifiable outcome

  • Over £150m invested in 120+ portfolio companies since 2001
  • +2 more outcomes

Companies that use Cambridge Angels group

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Cambridge Angels group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cambridge Angels group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Emmi Nicholl Promotion to CEOcoreOthers · 23 October 2025Emmi Nicholl was promoted to CEO of Cambridge Angels, overseeing the group's activities, screening investment opportunities, and facilitating pitching and support events.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Cambridge Angels group competitors and assessment

Company assessment

Broad incumbents

  • Crowdcube: UK equity crowdfunding platform enabling retail and HNW investors to back early-stage companies. Competes with Cambridge Angels for UK seed-stage deal flow and is increasingly used by founders seeking faster, broader capital raises with marketing benefits.
  • Connect Ventures: London-based early-stage venture fund investing in European technology companies at seed and pre-seed. Comparable in early-stage UK technology focus but operates via institutional fund structure rather than angel syndication.
  • Amadeus Capital Partners: UK deep-tech venture capital firm and corporate member of Cambridge Angels. Provides later-stage capital to portfolio companies and overlaps in thesis (technology-rich, IP-heavy UK companies) but operates at Series A and beyond rather than seed — making it both a partner and a broader incumbent.
  • Octopus Ventures: UK venture arm of Octopus Group investing across seed to growth stages in UK and European technology companies. Comparable as a UK-based investor targeting early-stage B2B technology with similar sector breadth but materially larger cheque sizes.
  • Albion VC: UK early-stage venture capital firm and corporate member of Cambridge Angels. Compares as an institutional early-stage investor into UK technology and healthcare, with a similar sector focus but operating through larger fund vehicles rather than an angel syndicate.

Emerging players

  • SeedLegals: UK startup funding and legal infrastructure platform that streamlines fundraising, cap tables, and SEIS/EIS administration. Comparable as part of the broader UK seed-funding ecosystem that Cambridge Angels operates in, though focused on tooling rather than direct investment.

Direct peers

  • SyndicateRoom: UK angel-led investment platform/network that co-invests alongside lead angels into early-stage UK companies. Comparable in target market (UK seed-stage companies), investor base (HNW individuals), and value proposition (curated deal flow plus syndicate structure).
  • Parkwalk Advisors: UK investment firm specialising in university spin-out and IP-rich technology investments. Parkwalk is a corporate member of Cambridge Angels but also operates its own funds targeting a very similar thesis, making it a close functional peer in the Cambridge deep-tech ecosystem.
  • Oxford Investment Opportunity Network (OION): UK university-region angel network based in Oxford with a structurally similar model — pooling HNW investors (often exited operators) to invest in early-stage UK companies. Directly comparable to Cambridge Angels as a fellow 'Oxbridge-adjacent' angel network targeting IP-rich spin-outs and B2B startups.
  • Angel Investment Network: UK-headquartered online platform connecting angel investors with early-stage companies seeking funding. Comparable as a curated deal flow intermediary for HNW investors investing into UK startups, though with a broader geographic mandate than Cambridge Angels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cambridge Angels group social profiles

Digital presence

Cambridge Angels group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cambridge Angels group leadership team

Management profile

Number of profiles

Profiles16 records

Cambridge Angels group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cambridge Angels group M&A and investment

M&A and investment

M&A

Investments139 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Angels group

What does Cambridge Angels group do?

Cambridge Angels is an invitation-only business angel network that pools capital from up to 65 high-net-worth members (predominantly exited entrepreneurs) to invest £150k–£1.5m equity rounds into early-stage UK technology and healthcare companies. It additionally provides portfolio support through mentorship, office hours, pitching sessions, and ecosystem networking, without charging any pitching, due diligence, or carry fees to investee companies.

Is Cambridge Angels group a public or private company?

Cambridge Angels group is a private company. It is classified as management employee owned and is currently operating.

When was Cambridge Angels group founded?

Cambridge Angels group was founded in 2001. It employs 51 to 100 people.

Where is Cambridge Angels group based?

Cambridge Angels group is headquartered in London, United Kingdom, in the Europe region.

How does Cambridge Angels group make money?

One revenue line is on record: membership fees and sponsorship.

Who are Cambridge Angels group's main competitors?

Broad incumbents on record are Crowdcube, Connect Ventures, Amadeus Capital Partners, Octopus Ventures and Albion VC. SeedLegals is listed as an emerging player. Direct peers are SyndicateRoom, Parkwalk Advisors, Oxford Investment Opportunity Network (OION) and Angel Investment Network.

Does Cambridge Angels group have an API?

No public API is recorded for Cambridge Angels group.

What industry is Cambridge Angels group in?

Cambridge Angels group's product category is Angel Investment / Early-Stage Venture Capital. Its primary akta.pro industry code is FSANAAAI, Micro-VC & Angel Funds. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmagEdinburgh based Singular Photonics raises £1.6m led by ACF Investors and Wren CapitalSingular Photonics, an Edinburgh-based hardware startup, raised £1.6m in a seed round led by ACF Investors and Wren Capital. The funding will accelerate development of single-photon avalanche diode sensors for machine vision, industrial automation, and medical imaging. The company reports full-year 2025 sales doubled in 2026 to date.StartupmagUndo raises £1.5m led by Cambridge Innovation Capital and Sir Peter MichaelUndo closed a £1.5m seed round in April 2015 led by Cambridge Innovation Capital and Sir Peter Michael. The funds will expand its reversible debugging tools for Linux and Android and hire commercial and marketing leads. The company reports its tools are used by over 1,000 developers at customers like Cadence and Mentor Graphics.FinSMEsFLIT Raises £1.2M in FundingFlit, a Cambridge-based folding e-bike company, raised £1.2M from ACF Investors, Cambridge Angels, and Tony Purnell. The funds will ramp up production of the FLIT M2 at its Cambridge facility. The company previously received an Innovate UK grant in 2023.Silicon CanalsUK’s FLIT raises €1.4M to produce folding e-bikes built using aerospace-grade techniquesFLIT, a UK folding e-bike company, raised £1.2M (€1.4M) from ACF Investors, Cambridge Angels, and Tony Purnell. The funding will ramp up production of the FLIT M2 at its Cambridge facility, with deliveries to UK customers starting in October 2024.StartupriseFLIT funding news – UK-based FLIT Raises £1.2M in New FundingFLIT, a UK-based folding electric bike maker, raised £1.2M in new funding from ACF Investors, Cambridge Angels, and Tony Purnell. The funds will scale production of the FLIT M2 at its Cambridge facility, with deliveries to UK customers starting in October 2024.PharmiWeb.comCambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical developmentMonument Therapeutics, a spin-out from Cambridge Cognition, has secured £1.5 million in funding through a £1.0 million raise and a £0.5 million grant to advance the clinical development of MT1988 for schizophrenia-related cognitive impairment. The fundraising was led by angel networks including Cambridge Angels and Manchester Angels, while Cambridge Cognition maintained its stake without participating. Monument expects to commence initial clinical trials in the coming weeks, with Phase 2 trials anticipated to begin in early 2025.FinSMEsStamp Free Raises £600K in FundingEdinburgh-based digital postage company Stamp Free Limited raised £600,000 in funding led by R42 Group and Cambridge Angels. The company plans to utilize the capital to expand sales and marketing efforts while accelerating product development for its AI-driven digital postage solution.BusinessCloud£1m funding for ‘future of pest control’Spotta, a Cambridge start-up, raised nearly £1m in seed funding, with a £934,000 investment deal from Cambridge Angels and REMUS. The funding will support hiring, two new products, and international expansion beyond the UK, US, and Europe. Spotta aims to address the £320bn insect pest problem while reducing pesticide use.Business InsiderA Google VC explained why Cambridge has the edge over Oxford on tech startupsGV partner Tom Hulme said Cambridge has the edge over Oxford in tech startups, citing Cambridge Angels and CIC as efficient funnels. He noted Oxford's world-class research hasn't translated into startup throughput. GV invested in Oxford Science Innovation, which raised £580 million and has made over 40 investments.